Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus

被引:25
|
作者
Chatzidionysiou, Katerina [1 ]
Samoli, Evangelia [2 ]
Sfikakis, Petros P. [1 ]
Tektonidou, Maria G. [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Dept Propaedeut & Internal Med 1, Joint Rheumatol Program, Laiko Hosp,Med Sch, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece
关键词
D O I
10.1136/annrheumdis-2019-216367
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:304 / +
页数:4
相关论文
共 50 条
  • [21] Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials
    Sun, Fangfang
    Geng, Shikai
    Wang, Haiting
    Wang, Huijing
    Liu, Zhe
    Wang, Xiaodong
    Li, Ting
    Wan, Weiguo
    Lu, Liangjing
    Teng, Xiangyu
    Morel, Laurence
    Ye, Shuang
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [22] Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme
    Maslen, Toni
    Bruce, Ian N.
    D'Cruz, David
    Ianosev, Mihaela
    Bass, Damon L.
    Wilkinson, Christel
    Roth, David A.
    LUPUS SCIENCE & MEDICINE, 2021, 8 (01):
  • [23] Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial
    Tanaka, Yoshiya
    Bass, Damon
    Chu, Myron
    Egginton, Sally
    Ji, Beulah
    Struemper, Herbert
    Roth, David
    MODERN RHEUMATOLOGY, 2019, 29 (03) : 452 - 460
  • [24] Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
    Stohl, William
    Schwarting, Andreas
    Okada, Masato
    Scheinberg, Morton
    Doria, Andrea
    Hammer, Anne E.
    Kleoudis, Christi
    Groark, James
    Bass, Damon
    Fox, Norma Lynn
    Roth, David
    Gordon, David
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (05) : 1016 - 1027
  • [25] Magnitude and Duration of Early Response with Tofacitinib: Post-Hoc Analysis of Two Phase 3, Placebo-Controlled Studies
    Aletaha, Daniel
    Kivitz, Alan
    Valenzuela, Guillermo
    Tesser, John
    Hays, Steven
    Li, Huihua
    Connell, Carol A.
    Bananis, Eustratios
    Soonasra, Arif
    Smolen, Josef
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [26] MAGNITUDE AND DURATION OF EARLY RESPONSE WITH TOFACITINIB: POST-HOC ANALYSIS OF TWO PHASE 3, PLACEBO-CONTROLLED STUDIES
    Aletaha, D.
    Kivitz, A.
    Valenzuela, G.
    Tesser, J.
    Hays, S.
    Li, H.
    Connell, C. A.
    Bananis, E.
    Soonasra, A.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 272 - 273
  • [27] POOLED SAFETY ANALYSIS OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THREE RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL TRIALS
    Dorner, T.
    Tanaka, Y.
    Mosca, M.
    Bruce, I. N.
    Cardiel, M.
    Morand, E. F.
    Petri, M. A.
    Silk, M.
    Dickson, C.
    Meszaros, G.
    Issa, M.
    Zhang, L.
    Wallace, D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 639 - 639
  • [28] The efficacy and safety of lurasidone in bipolar I depression with and without rapid cycling: A pooled post-hoc analysis of two randomized, placebo-controlled trials
    Kato, Masaki
    Masuda, Takahiro
    Sano, Fumiya
    Kato, Tadafumi
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 337 : 150 - 158
  • [29] Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials
    McIntyre, Roger S.
    Weiller, Emmanuelle
    Zhang, Peter
    Weiss, Catherine
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 201 : 116 - 123
  • [30] Chinese Herbal Medicine for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis of Randomized, Placebo-Controlled Trials
    Wang, Ying
    Han, Mei
    Pedigo, Christopher E.
    Xie, Zhi-Min
    Wang, Wei-Jie
    Liu, Jian-Ping
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2021, 27 (10) : 778 - 787